Artwork

Innhold levert av BioTalent Canada. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av BioTalent Canada eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Biotechnology – One Part Science, Two Parts Human Resources

39:24
 
Del
 

Manage episode 342189739 series 3398740
Innhold levert av BioTalent Canada. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av BioTalent Canada eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Bio Tech companies are committed to the business of science. It’s what we do every day. But there’s another commitment they’re engrossed in… attracting and retaining talented people.

It’s an industry undergoing dramatic change with forecasts indicating the number of jobs will soon outnumber candidates by a ratio of four. So, what are Biotech leaders doing to prepare and respond to this?

In episode one, host Rob Henderson, the CEO of BioTalent Canada talks with Reg Joseph, CEO of Health Cities, a not-for-profit corporation working with clinicians, innovators, philanthropic organizations, and companies to develop new models of care to drive better health outcomes. Reg shares some of his strategies to respond to the talent crunch.

Guest: Reg Joseph, CEO

Health Cities, Chair BioTalent Canada

Reg has 20 years’ experience spanning the health, technology and investment sectors. At Health Cities, Reg is focused on developing new pathways for healthcare delivery to drive better health outcomes and economic growth for our region. Reg has a B.Sc. in Physiology and an MBA in Finance.

Health Cities Website

BioTalent Canada Website

See the latest news on our website

Contact BioTalent Canada by email

  continue reading

12 episoder

Artwork
iconDel
 
Manage episode 342189739 series 3398740
Innhold levert av BioTalent Canada. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av BioTalent Canada eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Bio Tech companies are committed to the business of science. It’s what we do every day. But there’s another commitment they’re engrossed in… attracting and retaining talented people.

It’s an industry undergoing dramatic change with forecasts indicating the number of jobs will soon outnumber candidates by a ratio of four. So, what are Biotech leaders doing to prepare and respond to this?

In episode one, host Rob Henderson, the CEO of BioTalent Canada talks with Reg Joseph, CEO of Health Cities, a not-for-profit corporation working with clinicians, innovators, philanthropic organizations, and companies to develop new models of care to drive better health outcomes. Reg shares some of his strategies to respond to the talent crunch.

Guest: Reg Joseph, CEO

Health Cities, Chair BioTalent Canada

Reg has 20 years’ experience spanning the health, technology and investment sectors. At Health Cities, Reg is focused on developing new pathways for healthcare delivery to drive better health outcomes and economic growth for our region. Reg has a B.Sc. in Physiology and an MBA in Finance.

Health Cities Website

BioTalent Canada Website

See the latest news on our website

Contact BioTalent Canada by email

  continue reading

12 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett